Oncology Letters

Journal

Overview
Identity

Publication Venue For

D Rhamnose β-hederin against human breast cancer by reducing tumor-derived exosomes. 16:5172-5178. 2018

The anti-tumor effects of Mfn2 in breast cancer are dependent on promoter DNA methylation, the P21^Ras motif and PKA phosphorylation site. 15:8011-8018. 2018

A hederagenin saponin isolated from Clematis ganpiniana inducesapoptosis in breast cancer cells via the mitochondrial pathway. 15:1737-1743. 2018

Regulation of HtrA2 on WT1 gene expression under imatinib stimulation and its effects on the cell biology of K562 cells. 14:3862-3868. 2017

MARCKS phosphorylation is modulated by a peptide mimetic of MARCKS effector domain leading to increased radiation sensitivity in lung cancer cell lines. 13:1216-1222. 2017

MicroRNA-20a contributes to cisplatin-resistance and migration of OVCAR3 ovarian cancer cell line. 14:1780-1786. 2017

Increased autophagic response in a population of metastatic breast cancer cells. 12:523-529. 2016

Globular adiponectin enhances invasion in human breast cancer cells. 11:633-641. 2016

Combined therapy against recurrent and intracranial invasion of sinonasal hemangiopericytoma: A case report. 10:287-290. 2015

Phox2B correlates with MYCN and is a prognostic marker for neuroblastoma development. 9:2507-2514. 2015

Hypoxia regulates Toll-like receptor-9 expression and invasive function in human brain cancer cells in vitro. 8:266-274. 2014

Secretory breast carcinoma in a 12-year-old girl: A case report. 8:1635-1637. 2014

International Standard Serial Number (issn)

1792-1074

Electronic International Standard Serial Number (eissn)

1792-1082